The capsaicin receptor TRPV1, one of the major transduction channels in the pain pathway, integrates information from extracellular milieu to control excitability of primary nociceptive neurons. Sensitization of TRPV1 heightens pain sensation to moderately noxious or even innocuous stimuli. We report here that oxidative stress markedly sensitizes TRPV1 in multiple species' orthologs. The sensitization can be recapitulated in excised insideout membrane patches, reversed by strong reducing agents, and blocked by pretreatment with maleimide that alkylates cysteines. We identify multiple cysteines required for full modulation of TRPV1 by oxidative challenges. Robust oxidative modulation recovers the agonist sensitivity of receptors desensitized by prolonged exposure to capsaicin. Moreover, oxidative modulation operates synergistically with kinase or proton modulations. Thus, oxidative modulation is a robust mechanism tuning TRPV1 activity via covalent modification of evolutionarily conserved cysteines and may play a role in pain sensing processes during inflammation, infection, or tissue injury.
The capsaicin receptor TRPV1, one of the major transduction channels in the pain pathway, integrates information from extracellular milieu to control excitability of primary nociceptive neurons. Sensitization of TRPV1 heightens pain sensation to moderately noxious or even innocuous stimuli. We report here that oxidative stress markedly sensitizes TRPV1 in multiple species' orthologs. The sensitization can be recapitulated in excised insideout membrane patches, reversed by strong reducing agents, and blocked by pretreatment with maleimide that alkylates cysteines. We identify multiple cysteines required for full modulation of TRPV1 by oxidative challenges. Robust oxidative modulation recovers the agonist sensitivity of receptors desensitized by prolonged exposure to capsaicin. Moreover, oxidative modulation operates synergistically with kinase or proton modulations. Thus, oxidative modulation is a robust mechanism tuning TRPV1 activity via covalent modification of evolutionarily conserved cysteines and may play a role in pain sensing processes during inflammation, infection, or tissue injury.
covalent modification ͉ pain A nimals living in aerobic environments face a constant challenge from oxidative stress. Chemical reactions of cellular constituents with oxidants alter protein functions, disrupt cellular communication signaling networks, or stimulate aberrant cell growth and differentiation through modification of genetic messages. Healthy cells have a wealth of reducing agents to combat environmental oxidative stress. The harm from oxidative chemicals is exacerbated by tissue injury, in that the damaged cell loses its physical barrier against reactive chemicals and fails to replenish cytoplasmic antioxidants.
Pain, the sensation for detecting tissue damage, also worsens during oxidative stress. Like other sensory modalities, pain displays short-and long-term plasticity. Application of oxidative chemicals evokes sharp pains by immediately activating painsensing neurons. In contrast, persistent or chronic oxidative challenge causes sustained pain intensified out of proportion to the severity of injury, or hyperalgesia, which increases our awareness of unrepaired tissue damage and assists us in actively avoiding incidental harms.
Sensory neurons use specialized transduction channels to convert environmental insults into electrical signals (1) (2) (3) (4) (5) . Activation of both the capsaicin receptor TRPV1 and the mustard oil receptor TRPA1 is the principal excitatory drive for thermal or chemical nociceptors. Noxious heat, capsaicin, and acidic pH activate TRPV1; reactive chemical substances covalently modify and activate TRPA1 (6, 7) . Excessive activation of TRPV1 and TRPA1 is an obligatory step in developing thermal hyperalgesia (8) (9) (10) (11) .
Chemical reactions between transduction channels and reactive chemicals have been recognized as effective means to alter their sensitivities to input stimuli. Covalent modification of TRPA1 by allyl-isothiocyanate or alkylating agents excites pain fibers, evoking acute pain and nocifensive behaviors. Hydrogen peroxide (H 2 O 2 ) and ␣,␤-unsaturated aldehydes acutely activate TRPA1 (12) (13) (14) (15) . The reactive compound allicin from garlic and nitric oxide activate TRPA1 and TRPV1 via covalent modification (16) (17) (18) (19) (20) (21) (22) , providing examples for oxidative stress-related pain or hyperalgesia. H 2 O 2 was discovered to mediate thermal hyperalgesia through TRPV1-dependent and -independent mechanisms; TRPV1 is required for long sustenance of thermal hypersensitivity after strong oxidative challenge (23) .
Modulation of TRPV1 by oxidative chemicals in neurons is masked by prominent TRPA1 activation, owing to overlapping expression (3, 10) and complex cross desensitization between these two channels (24, 25) . Membrane-permeable hydrogen peroxide potentiates heat activation of TRPV1, while membrane-impermeable oxidants are ineffective (26) . The biochemical basis of H 2 O 2 modulation, however, was undetermined. Oxidative environments also reduce capsaicin-evoked TRPV1 currents due to decreased effective agonist concentration caused by chemical reactions between capsaicin and oxidants (26, 27) .
We found that TRPV1 activation by capsaicin in fact increases substantially following oxidative stress. The sensitization is long standing and involves covalent modification of conserved cysteines. Oxidation overrides receptor desensitization and operates synergistically with other excitatory modulations to supersensitize the receptor, helping to maintain thermal hyperalgesia related to oxidative damage. Covalent modification of cysteines is thus an important biochemical mechanism exploited by primary sensory neurons to increase their excitability, either by direct activation or by amplification of responses of nociceptive transduction channels. Fig. S1 ). We also observed the potentiation of voltage-dependent, strongly outwardly-rectifying hTRPV1 currents (16.9-Ϯ 4.6-fold, pH 6.4-induced, n ϭ 6) (Fig.  1C) in Xenopus oocytes, which have large size and abundant antioxidant reserves to withstand prolonged recording with minimal changes of cellular contents. These results indicate that H 2 O 2 slowly but strongly sensitizes TRPV1 in heterologous systems. requirement for activation of multiple pathways in different intracellular compartments. In excised inside-out patches, H 2 O 2 modulated capsaicin-induced TRPV1 currents with similar robustness (32.9-Ϯ 10.3-fold for 1 M capsaicin, n ϭ 8) and slow rate as in whole cells ( Fig. 1 D and E) , favoring the former hypothesis. The receptor exhibits a modest shift of EC 50 and an increase of currents at 30 M capsaicin (Fig. 1D , n ϭ 6). H 2 O 2 sensitization thus at least partly involves an increase of capsaicin efficacy. H 2 O 2 -potentiated TRPV1 stayed sensitized until application of strong reducing agents such as 2,3-dimercaptopropanol (BAL) or dithiothreitol (DTT) (Fig. 1E) . Glutathione (GSH), a weaker reducing agent, did not effectively reverse H 2 O 2 sensitization. The modulation in an excised membrane patch was as pronounced as that in a whole cell, followed similar kinetics, and could be slowly reversed by dithiol reducing agents, arguing for direct covalent modification of reactive cysteines as the underlying biochemical mechanism.
Results

H2O2
The slow rate of H 2 O 2 -catalyzed reaction required us to search for other cysteine-reactive compounds with faster reaction kinetics as chemical surrogates for mechanistic analysis. Since H 2 O 2 reacts with cysteines to convert physically approximated cysteines into disulfides, we used dithio-bis-nitrobenzoic acid (DTNB) and phenylarsine oxide (PAO), two compounds that link thiols in physical proximity, to examine oxidation effects on TRPV1.
DTNB, a negatively charged membrane-impermeable chemical, is used to determine sidedness of reactive cysteines relative to plasma membrane. Besides forming mixed disulfides with proteins via a disulfide exchange mechanism, DTNB facilitates disulfide bond formation between vicinal cysteines. Although covalent bonds between DTNB and cysteines can be reversed by monothiol reducing agents like GSH, inter-cysteine disulfide bonds can only be reversed by stronger reducing agents (e.g., BAL or DTT) (28) . DTNB potentiated basal, acid-or capsaicininduced TRPV1 currents (3.26 Ϯ 1.01 ϫ 10 1 -fold, n ϭ 5, Figs. S2 and S3). Oxidation thus efficiently tunes TRPV1 responsiveness to noxious stimuli. We observed similar modulation in capsaicininsensitive chicken TRPV1 ( Fig. S4) (29) . Sensitivity to oxidative chemicals appears to be a fundamental TRPV1 regulatory mechanism evolutionarily conserved in several vertebrate species.
In excised inside-out patches, DTNB enhanced basal currents and those induced by agonists. However, only rates but not maximal extents of stimulation depend on DTNB concentration (Fig. S5 ). DTNB stimulation is more likely due to a chemical reaction than a reversible receptor-ligand interaction. Reminiscent of the H 2 O 2 effects, DTNB actions could only be reversed slowly by strong reducing agents, but not by GSH. These data favor formation of disulfide bonds between vicinal cysteines as the chemical basis of TRPV1 sensitization.
PAO forms cyclic dithiaarsenane adducts with thiols in X-C-X-X-C-X motifs to irreversibly inactivate many cellular signaling molecules (30) (31) (32) (33) (34) . We thus exploited its membrane permeability and reactivity on vicinal cysteines (while sparing free monothiols) to dissect TRPV1 modulation. PAO sensitized capsaicinevoked responses of recombinant receptors (7.58 Ϯ 2.69 ϫ 10 1 -fold, n ϭ 38) (Fig. S6A ) and neuronal TRPV1 (19.0-Ϯ 9.5-fold, n ϭ 6) (Fig. S6B ). It also stimulated basal or acidevoked currents, notably to a greater degree than DTNB ( Fig. 2A and Fig. S7A ). PAO and DTNB share the same acceptor cysteines for their stimulatory effects on TRPV1, because neither could further potentiate the maximal effect of the other (Fig. 2B , n ϭ 6, and Fig. S7B , n ϭ 5). PAO occlusion of DTNB potentiation was abolished by BAL treatment, after which either PAO or DTNB could robustly potentiate TRPV1 (Fig. 2C , n ϭ 4). By reducing inter-cysteine disulfide bonds back to free thiols to relieve PAO occlusion, BAL allows subsequent potentiation. Evidently, PAO and DTNB target a common set of cysteines in TRPV1 to evoke their modulatory effects.
Cysteine forms covalent adducts with reactive electrophiles like mustard oil, unsaturated aldehydes, or maleimides to activate TRPA1. Nevertheless, N-methyl maleimide (NMM) treatment caused a small inhibition of TRPV1 (Fig. 3A) . NMM did react with TRPV1 cysteines: it abolished further TRPV1 modulation by other oxidative chemicals (Fig. 3B , n ϭ 5). Conversely, oxidant-potentiated TRPV1 becomes refractory to NMM (data not shown). Irrespective of the functional consequence of cysteine modification, the first cysteine-reactive chemical modified accessible thiols, protecting them from the attack by next compound. Although TRPV1 cysteines are amenable to modification by a host of reactive chemicals, only in some cases does this evoke channel modulation. Oxidative sensitization of TRPV1 apparently has stringent structural requirements. We exploited differential membrane permeability of DTNB and PAO to locate reactive cysteines for sensitization. TRPV1 did not respond to extracellular DTNB in Ca 2ϩ imaging. However, subsequent addition of PAO elicited a prominent response ( Fig. 3C and Movies S1 and S2). Contrary to its effectiveness in inside-out patches, DTNB lacked activation or sensitization effects and failed to occlude the subsequent PAO action in imaging experiments. Modulation-sensitive cysteines must reside intracellularly, since DTNB cannot cross plasma membrane.
Conserved Cysteines Mediate Oxidative Sensitization of TRPV1.
To identify the cysteines involved in oxidative modulation, we examined oxidant sensitivity of chimeric channels between TRPV1 and TRPV2. A chimeric channel (ChV2-V1) containing transmembrane and C-terminal domains of TRPV1 successfully transferred potentiation to TRPV2 (Fig. S8) . Seven out of eight transferred cysteines are distributed between the fifth transmembrane segment and the end of the C terminus. When this region was further replaced with TRPV2 sequence (Fig. S8B) , the new chimera ChV2-V1-V2 lost the acquired oxidative sensitization. We initially expected to eliminate the sensitization by substituting all these seven cysteines in wild-type TRPV1. The septuple cysteine mutant rTRPV1-7C remained potentiated by oxidation, however (Fig. S8C) . Although modification of cysteines within the TM5-CT region of TRPV1 contributes to channel sensitization, N-terminal cysteines apparently also participate in oxidative sensitization.
Due to dispersal of modulation-relevant cysteines throughout the sequence, we used cysteine reversion mutagenesis to delineate the full set of cysteine residues contributing to oxidative modulation. Our strategy was to remove all cysteine residues from TRPV1 and then evaluate the ability of various cysteine reversion mutants to undergo potentiation. Initial experiments with a cysteineless rat TRPV1 were confounded by a substantial reduction of functional expression of this channel. However, a cysteineless version of chicken TRPV1 ( Cys-cTRPV1) still exhibited sufficient surface expression, and, as expected, was insensitive to oxidative modulation. Since oxidative modulations of mammalian and avian TRPV1 likely proceed via similar mechanisms (Fig. S8D) , we mapped evolutionarily conserved sites of oxidant potentiation by reverting cysteines individually in Cys-cTRPV1, thereby identifying C772 and C783 as critical cysteines in cTRPV1 C terminus for sensitization (Fig. 4A) . Because the potentiation is mediated by intramolecular disulfide bonds, sensitization of C772 or C783 single revertant mutants by PAO suggests that either residue forms inter-subunit disulfide bonds to stimulate TRPV1. Unexpectedly, our reversion analysis also reveals the inhibitory role of three cysteines unique to cTRPV1. Located close to the ends of N-or C terminus but absent in the mammalian TRPV1, Cys 66, 111, and 832 are oxidized by PAO to suppress basal cTRPV1 activities (Fig. 4A) .
The absence of single revertants in N terminus to restore potentiation suggests that one or more pairs of cysteines in N terminus form intra-subunit disulfide bonds to potentiate cTRPV1. Subdivision of cysteines in N terminus into small clusters led to identification of modulation-sensitive Cys-cTRPV1 ϩ 3C, the triple revertant with C369, C393, and C397. Among three combinations of double revertants, only the Cys-cTRPV1C393C397 showed PAO sensitization. Heterotetrameric channels formed by co-expression of Cys-cTRPV1C393 and Cys-cTRPV1C397 were insensitive to PAO, indicating that C393 and C397 form intra-subunit disulfide bonds to sensitize cTRPV1 (Fig. S9A) . Presumably seven out of 18 cysteines participate in cTRPV1 modulation. Receptor potentiation dominates when stimulations and inhibitions coexist; inhibition becomes obvious only when sufficient stimulatory covalent modifications are ablated by mutations.
Three of four cysteines required for cTRPV1 oxidative sensitization are conserved in mammalian receptors (Fig. 4B) . Surprisingly, PAO still potentiated mammalian TRPV1 triple mutants lacking the three conserved cysteines (C387, C391, and C767 in hTRPV1). Given that reactive chemical allicin activates rat TRPV1 by covalent modification of C157 (C158 in hTRPV1) (18) and that oxidative or alkylating electrophilic chemicals share the same reactant cysteines within TRPV1, we tested the potential reciprocal occlusion between allicin and PAO effects. We hence found C158 to be the missed acceptor cysteine in our reversion analysis (Fig. S9B) . The quadruple mutant with further replacement of C158 became PAO and H 2 O 2 resistant (Fig. S9C) . Moreover, two hTRPV1 triple mutants (C158AC387SC767S and C158AC391SC767S) are also PAO insensitive (Fig. S9D) , either expressed alone or co-expressed. It follows that C387 and C391 within the same subunit form a disulfide bond, while C158 or C767 forms inter-subunit disulfide bonds (Fig. 4C) .
Oxidation Overrides Desensitization and Supersensitizes Receptors
Prepotentiated by Other Pathways. In an injured tissue, many forms of TRPV1 modulations frequently coexist. They may have additive or antagonistic effects on each other. How will oxidative sensitization affect TRPV1 for its signal integrator role? Ca 2ϩ -dependent receptor desensitization upon persistent exposure to agonists is an important mechanism to reduce TRPV1 activity. Desensitization blunts all modes of TRPV1 activation (35) , partly explaining the therapeutic efficacy of capsaicin as a painkiller (36) . We asked whether receptor desensitization would block subsequent potentiation by oxidation. We recorded from a cell-attached patch in the presence of extracellular Ca 2ϩ to induce TRPV1 desensitization (Fig. 5A ). The membrane patch was then excised into the inside-out configuration. Desensitized receptors remained refractory to agonist challenge after patch excision, but could later be strongly potentiated by the standard PAO stimulation protocol (Fig. 5A) . The ability of oxidation to potentiate desensitized receptors was also observed in the cell-attached configuration (Fig. 5B) . We also prestimulated rat TRPV1 by PAO in the cell-attached configuration and then challenged with capsaicin, to determine whether oxidized receptors become supersensitized to obliterate desensitization. Desensitization, although occurring in PAO-sensitized receptors, was less extensive than that from non-PAO treated cells within the same duration of capsaicin exposure (Fig. 5C ). Oxidized receptors are more resistant to capsaicin-induced desensitization, while desensitized receptors can be primed by strong oxidative stresses to resume their capacity to sense noxious stimuli.
TRPV1 can be activated by several different modes of stimuli, including heat, capsaicin, and acid. By summing effects of small activating stimuli within each mode, TRPV1 acts as a signal integrator to effectively detect the coexistence of multiple harmful stimuli. Mild acidic pH (pH 6.4) or receptor phosphorylation alone is a weak activator for TRPV1 (35, 37) . However, simultaneous presence of both stimuli elicits a response bigger than the sum of individual challenges. In our test for oxidized TRPV1 to amplify responses induced by other modulation pathways, we find a colossal synergism of oxidation, phosphorylation and tissue acidosis (Fig. 6A) . However, sensitization of TRPV1 by H 2 O 2 in phorbol-ester stimulated cells still has similar slow kinetics and concentration dependence (Fig. 6B) . The oxidative sensitization of TRPV1 remains robust in phorbol ester-resistant TRPV1 mutants (Fig. S9E) (38) . Hence, oxidation represents an independent pathway from phosphorylation, desensitization, and acidic extracellular pH, acting to increase the gain of this nociceptive transduction channel.
Discussion
Molecules activating or sensitizing nociceptors are frequently involved in inflammation or tissue injuries. Oxidative stress is no exception (39) . Reactive oxygen species (ROS) are known to cause persistent pain (40) (41) (42) (43) (44) C111  C164  C239  C264  C269  C369  C393  C397  C540  C586  C624  C641  C722  C748  C772  C783 are indiscriminative (45) , compromising multiple cell types to exacerbate tissue inflammation and nociception. Although a significant part of hyperalgesia can arise from action of ROS on the spinal cord (44, 46) , sensory transduction channels in peripheral nerves may also contribute to pain related to oxidation.
TRPV1 is the principal transduction channel serving as a polymodal detector. Many cellular signaling pathways modulate TRPV1 to alter the excitability of nociceptive neurons. Despite the importance of oxidative stress in pain sensitivity, its role in TRPV1 modulation was barely understood. We demonstrated that they evoke potent and long-lasting sensitization of TRPV1 via formation of inter-cysteine disulfide bonds within its cytoplasmic termini.
Sensitization of nociception from a single oxidative challenge displays multiple temporal components. TRPA1 is strongly activated by covalent cysteine modification, and suitable for detecting acute cellular injuries from reactive chemicals. In contrast, oxidative modulation of TRPV1 develops slower, primarily sensitizing instead of activating the receptor. However, the robustness of oxidative sensitization of TRPV1 is no less than that by other proalgesic substances. Direct modification of TRPV1 may thus contribute to elevated pain sensation under oxidative stress. The long-lasting sensitizing effect of TRPV1 oxidation may be partly from relative resistance of inter-cysteine disulfide bonds to glutathione, the most abundant cellular reducing agent. The large surface to volume ratio of nerve endings, where transduction occurs, presumably further increases the vulnerability of membrane proteins therein to oxidative damages. Products of oxidation may accumulate analogous to the accrual of oxidized proteins in aging (47) (48) (49) or other neurological disorders, like Alzheimer's disease, Parkinson's disease, and chronic neuropathic pain (44, (50) (51) (52) . Unless neurons repair or remove oxidized TRPV1, covalently modified receptors may reside in sensory nerves for an unduly long time and contribute to the development of chronic pain.
Both TRPV1 and TRPA1 are important for thermal hyperalgesia. Covalent modification of cysteines is also a shared biochemical mechanism to tune activities of both channels. However, the structural requirements for channel activation, the magnitude and time course of the resulting effects differ. Oxidizing chemicals or sulfhydryl-reactive methanethiosulfonate (MTS) compounds can form disulfides to sensitize or activate TRPV1, while an irreversible thioether linkage with maleimide has essentially no stimulatory effect. In contrast, both types of cysteine modification activate TRPA1. The two noiceptive transduction channels can differentiate among reactive chemical species. The intrinsic sensitivity of TRPA1 to local Ca 2ϩ entry results in positive feedback following initial exposure to oxidants, to evoke a large, self-potentiated acute activation rapidly (53, 54) . This acute Ca 2ϩ -dependent potentiation is absent in TRPV1, accounting for the slower effects of oxidants. Oxidative modulation of TRPV1 involves modification of many different cysteines participating in intra-and inter-subunit disulfide bonds, which can contribute quantally to overall TRPV1 modulation according to their reaction kinetics and stability. TRPV1 may thus respond in a graded fashion to different levels of oxidative stress. Intrinsic differences in mechanisms of channel gating by oxidants make TRPA1 a rapid, highly sensitive detector of acute oxidative stress, and TRPV1 a sensor for a broad range of oxidant concentrations over a long time. It will be interesting to investigate the relative contribution of TRPA1 and TRPV1 in different phases of hyperalgesia induced by reactive chemicals, which will aid the development of therapeutic strategies to counter acute and chronic pain.
Materials and Methods
Cell Culture and Heterologous Expression. HEK293 cells were cultured with MEM supplemented with 10% newborn calf serum and antibiotics. Cells were transfected with 300 ng wild-type or mutant receptors with or without 100 ng enhanced GFP plasmids using Lipofectamine reagents. Cells were plated on polyD-lysine coated coverslips and recorded 2-3 days following transfection. Stage VI oocytes [from Xenopus tropicalis anesthetized in 0.3% tricaine and prepared as described (55)] were microinjected with hTRPV1 or cTRPV1 cRNA (1 ng per oocyte) and kept in oocyte Ringer (OR-2) solution at room temperature. Recordings were done 5-10 days after microinjection. Molecular Biology. Chimeric receptors were generated by the overlapped extension PCR; single point mutants were constructed following QuikChange site-directed mutagenesis. cRNAs were synthesized using T7 mMessage Machine kit.
Ratiometric Ca 2؉ Imaging. Cells expressing rat TRPV1 were loaded with fura-2 AM. (5 M) for 2 h. Imaging experiments were carried out at room temperature (22°C), with a sampling rate of one frame every 2 (for Fig. 3 A and C) or 5 s (for Fig. 1B) , with 150 ms exposure time to either wavelength (340 and 380 nm) using a CCD camera driven by the Slidebook 4.2 software.
Electrophysiology. Data are expressed as mean Ϯ SEM. unless indicated otherwise. For oocyte recording, the extracellular solution contained (in mM) 5 HEPES or 5 PIPES, 96 NaCl, 1 MgCl 2, and 1 BaCl2, titrated to pH 7.4 or pH 6.4 with NaOH. Data were acquired using the pClamp 10 software (Molecular Devices). For mammalian cell recording, the standard extracellular solution had (in mM) 10 HEPES, 145 NaCl or CsCl, 1 MgCl 2 , and 1 CaCl 2 , pH 7.4; the standard internal solution contained 10 HEPES, 145 Na gluconate (or 140 Na gluconate plus 6 NaCl for whole cell recordings), 1 Mg(gluconate) 2, and 0.1 EGTA, pH 7.4. Access resistances of whole cell recording electrodes were 2-3 M⍀. Those of insideout patch recordings were between 0.2 and 0.4 M⍀. Pulse and PulseFit software (HEKA) was used for data acquisition and analysis. Cells or patches were stimulated with voltage ramps from -120 to ϩ 80 mV. Time lapsed changes in current amplitudes at the holding potential (Ϫ60 mV) were displayed.
Additional Information. For additional information on materials and methods, see SI Materials and Methods. 
